Antioxidant supplements in management of Parkinson's disease

Archives of the Balkan Medical Union

Volumn 44, Issue 2, 2009, Pages 142-145

  Ribarova, Fanny ^a,b   Stoimenova, Assena ^a   Popova, K ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b NONE   (Bulgaria)

Author keywords

Antioxidants; Coenzyme Q10; Food supplements; Parkinson's disease; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; ANTIOXIDANT; ASCORBIC ACID; CAROTENOID; CATALASE; CERULOPLASMIN; GLUTATHIONE; GLUTATHIONE REDUCTASE; LEVODOPA; RETINOL; SELEGILINE; SUPEROXIDE DISMUTASE; UBIDECARENONE;

DEGENERATIVE DISEASE; DIETARY INTAKE; DOPAMINERGIC TRANSMISSION; DRUG EFFICACY; HUMAN; HUNTINGTON CHOREA; NERVE CELL DEGENERATION; OXIDATIVE STRESS; PARKINSON DISEASE; PARKINSONISM; QUALITY OF LIFE; REVIEW; RISK REDUCTION; SUBSTANTIA NIGRA;

EID: 69849101641     PISSN: 15849244     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Aquilano K, Baldelli S, Rotilio G, Ciriolo MR. Role of Nitric Oxide Synthases in Parkinson's Disease: A Review on the Antioxidant and Anti-inflammatory Activity of Polyphenols. Neurochem Res., 33, (12):2416-2426, (2008).
2. Valko, M., Leibfritz, D., Mancol, J., Cronin, M.T., Mazur, M., Telser, J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem Cell Biol. 39 (1): 44-84, (2007).
3. Beal M.F., Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases. Biofactors, 9 (2-4), 261-266, (1999).
4. Shults C.W., Coenzyme Q10 in neurodegenerative diseases. Curr, Med. Chem., 10 (19), 1917-1921, (2003).
5. Vataserry GT, Bauer T, Dysken M. High doses of vitamin E in the treatment of disorders of the central nervous system in the aged, Am J Clin Nutr 70, 793-801 (1999). (Pubitemid 29512902)
6. DATATOP, The Parkinson Study Group, Impact on deprenyl and tocopherol treatment on Parkinson disease in DATATOP patients requiring levodopa, Ann. Neuro.,39, 37-45, (1996).
7. Prasad, K.N., Cole, W.C., Kumar, B. Multiple Antioxidants in the Prevention and Treatment of Parkinson's Disease, Journal of the American College of Nutrition, 18, 5, 413-423, (1999).
8. Beal M.F., Coenzyme Q10 as a possible treatment for neurodegenerative disease, Free Radic.Res. 36 (4), 455-460, (2002).
9. Zhang, S.M., Hernan, M.A., Chen, H., Spiegelman, D., Willet, W.C., Ascherio, A., Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk, Neurology 59, 1161-1169, (2002).
10. Sudha, K., Rao, A., Rao, S., Rao, A., Free radical toxicity and antioxidants in Parkinson's disease, Neurology India, 51, 1, 60-62, (2003). (Pubitemid 36908854)
11. Shults C.W., Coenzyme Q10 in neurodegenerative diseases. Curr. Med. Chem., 10 (19), 1917-1921, (2003).
12. Osakada,F., Hashinoa A., Kumea .T et al, α-tocotrienol provides the most potent neuroprotection among vitamin E analogs on cultured striatal neurons, Neuropharmacology 47, 904-915 (2004).
13. Khana,S., Roy, S.,Slivka,S.,et al Neuroprotective properties of the natural vitamin E α-tocotrienol., Stroke, 36, 2258-2264, (2005).
14. Wang, C.A., J.Y., Wen, L.L., Huang, Y.N., Chen, Y.T., Ku, M.S. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-medicated inflammation. Curr Pharm Des. 12 (27); 3521-3533, (2006).
15. Weber, C.A., Ernst, M.E., Antioxidants, Supplements and Parkinson's Disease, Ann Pharmacother, 40 (5) 935-938, (2006).
16. Young AJ, Johnson S, Steffens D.C. et al, CNS Spectr., 2007 Jan., 12 (1):62-68
17. Report on the European Research on the Functional Effects of Dietary Antioxidants EUROFEDA-QLK1-1999-00179, January 2003.